Goodwill and Intangible Assets (Additional Information) (Details) - USD ($) $ in Thousands	1 Months Ended	3 Months Ended		6 Months Ended
	May 31, 2023	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022	Aug. 22, 2022	Feb. 17, 2022
Goodwill [Line Items]
Goodwill		$ 14,882		$ 14,882		$ 26,713
Amortization expense		4,958	$ 0	8,763	$ 0
Goodwill, impairment losses				0
Collaboration agreement
Goodwill [Line Items]
Amortization expense		5,000		8,800
In-process research and development
Goodwill [Line Items]
Useful life of Remaining In Process Research and Development	$ 2,600
In-process research and development | Collaboration agreement
Goodwill [Line Items]
Amortization expense	$ 68,700			0
La Jolla Pharmaceutical Company
Goodwill [Line Items]
Goodwill							$ 3,389
Future amortization expense, remainder of 2023		13,000		13,000
Future amortization expense, 2024		25,800		25,800
Future amortization expense, 2025		25,800		25,800
Future amortization expense, 2026		25,800		25,800
Future amortization expense, 2027		25,800		25,800
Future amortization expense, thereafter		124,500		124,500
Intangible assets pertain to product rights and developed technologies		151,000		151,000			$ 151,000
Entasis Therapeutics Holdings Inc
Goodwill [Line Items]
Goodwill								$ 11,493
Intangible assets pertain to product rights and developed technologies		106,700		106,700				$ 106,700
Entasis Therapeutics Holdings Inc | Collaboration agreement
Goodwill [Line Items]
Intangible assets pertain to product rights and developed technologies		35,400		35,400
Entasis Therapeutics Holdings Inc | In-process research and development
Goodwill [Line Items]
Intangible assets pertain to product rights and developed technologies		$ 71,300		$ 71,300